Predictive model for infection risk in myelodysplastic syndromes, acute myeloid leukemia and chronic myelomonocytic leukemia patients treated with azacitidine - Azacitidine Infection Risk Model - the Polish Adult Leukemia Group study

In conclusion, we selected a subset with high early risk for serious infection and worse clinical outcome among patients treated with azacitidine.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research